Patent · US Expired

Use

US6399617B1 · kind B1 · utility

5Cited by

4References

11Claims

0Family size

Assignee

Biovitrum AB · SE

Inventors

Patrizia Caldirola · Uppsala, SE
Sukhwinder Jossan · Uppsala, SE
Kjell S. Sakariassen · Oslo, NO
Jan Svartengren · Uppsala, SE

Key dates

Filing date	Jul 20, 2001
Grant date	Jun 4, 2002
Priority date	—
Expiry date	Jul 20, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/554
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a method of treatment or prophylaxis of obesity, comprising administering to a patient in need of such treatment a therapeutically effective amount of an aryl sulfonamide compound of formula (I) or formula (II) wherein the substituents are as described in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.